What Happened?
New York, NY-based Quentis-Therapeutics Appointed Michael Aberman as President and Chief Executive Officer
About the Company
Quentis is at the forefront of the next generation of immuno-oncology companies that are translating novel biology into new therapeutic approaches to help more patients benefit from immunotherapy.
About the Person
Michael Aberman is President and Chief Executive Officer at Quentis Therapeutics. Previously, Michael held various senior HR leadership roles in the industry.
Info Source
News
Short Profile